- Current report filing (8-K)
February 26 2009 - 8:44AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 25, 2009
RBC Life Sciences, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
NEVADA
|
|
000-50417
|
|
91-2015186
|
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
2301 CROWN COURT, IRVING, TEXAS
|
|
75038
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
972-893-4000
|
N/A
|
(Former name or former address if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 2.02 Results of Operations and Financial Condition
.
On February 25, 2009, RBC Life Sciences, Inc. issued a press release announcing its financial results for the year
ended December 31, 2008. A copy of the press release is being furnished as Exhibit 99.1 to this Form 8-K.
In accordance with General Instruction B.2 of Form 8-K, this information, including the exhibit related hereto, shall
not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be
deemed incorporated by reference in any disclosure document of the Company, except as shall be expressly set forth by
specific reference in such document.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
Description
99.1
|
|
Press release dated February 25, 2009 announcing financial results for the year ended December 31, 2008.
|
-2-
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Date: February 26, 2009
|
|
RBC Life Sciences, Inc.
|
|
|
By:
/s/ Steven E. Brown
|
|
|
|
|
|
Name: Steven E. Brown
Title: Chief Financial Officer
|
-3-
3
Exhibit Index
|
|
|
Exhibit Number
|
|
Description
|
99.1
|
|
Press release dated February 25, 2009 announcing financial
results for the year ended December 31, 2008
|
4
RBC Life Sciences (CE) (USOTC:RBCL)
Historical Stock Chart
From Sep 2024 to Oct 2024
RBC Life Sciences (CE) (USOTC:RBCL)
Historical Stock Chart
From Oct 2023 to Oct 2024